Novel stromal biomarkers in human breast cancer tissues provide evidence for the more malignant phenotype of estrogen receptor-negative tumors

Journal of Biomedicine and Biotechnology

Volumn 2011, Issue , 2011, Pages

  Khamis, Zahraa I ^a   Sahab, Ziad J ^b   Byers, Stephen W ^b   Sang, Qing Xiang Amy ^a  

^a FLORIDA STATE UNIVERSITY   (United States)

^b GEORGETOWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 ASSOCIATED RING DOMAIN PROTEIN 1; ESTROGEN RECEPTOR; T LYMPHOCYTE RECEPTOR ALPHA CHAIN; LYMPHOCYTE ANTIGEN RECEPTOR; REPRESSOR PROTEIN; TUMOR MARKER; ZNF350 PROTEIN, HUMAN;

ANGIOGENESIS; ARTICLE; BREAST CANCER; CANCER GROWTH; CANCER TISSUE; CARCINOGENESIS; CELL INTERACTION; EPITHELIUM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; MALIGNANT TRANSFORMATION; METASTASIS; PROTEOMICS; STROMA CELL; ZINC FINGER MOTIF; BIOSYNTHESIS; BREAST TUMOR; ENDOTHELIUM CELL; FEMALE; LEUKOCYTE; LIQUID CHROMATOGRAPHY; METABOLISM; METHODOLOGY; MYOFIBROBLAST; PATHOLOGY; PHENOTYPE; TANDEM MASS SPECTROMETRY; TWO DIMENSIONAL GEL ELECTROPHORESIS; WESTERN BLOTTING;

BLOTTING, WESTERN; BREAST NEOPLASMS; CHROMATOGRAPHY, LIQUID; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; ENDOTHELIAL CELLS; EPITHELIAL CELLS; FEMALE; HUMANS; LEUKOCYTES; MYOFIBROBLASTS; PHENOTYPE; PROTEOMICS; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; RECEPTORS, ESTROGEN; REPRESSOR PROTEINS; TANDEM MASS SPECTROMETRY; TUMOR MARKERS, BIOLOGICAL;

EID: 84855172843     PISSN: 11107243     EISSN: 11107251     Source Type: Journal    
DOI: 10.1155/2011/723650     Document Type: Article

References (38)

1. Shipitsin M., Campbell L. L., Argani P., Weremowicz S., Bloushtain-Qimron N., Yao J., Nikolskaya T., Serebryiskaya T., Beroukhim R., Hu M., Halushka M. K., Sukumar S., Parker L. M., Anderson K. S., Harris L. N., Garber J. E., Richardson A. L., Schnitt S. J., Nikolsky Y., Gelman R. S., Polyak K., Molecular definition of breast tumor heterogeneity Cancer Cell 2007 11 3 259 273 (Pubitemid 46349843)
2. Man Y. G., Focal degeneration of aged or injured myoepithelial cells and the resultant auto-immunoreactions are trigger factors for breast tumor invasion Medical Hypotheses 2007 69 6 1340 1357
3. Allinen M., Beroukhim R., Cai L., Brennan C., Lahti-Domenici J., Huang H., Porter D., Hu M., Chin L., Richardson A., Schnitt S., Sellers W. R., Polyak K., Molecular characterization of the tumor microenvironment in breast cancer Cancer Cell 2004 6 1 17 32 (Pubitemid 38903159)
4. Radisky D., Hagios C., Bissell M. J., Tumors are unique organs defined by abnormal signaling and context Seminars in Cancer Biology 2001 11 2 87 95 (Pubitemid 32423284)
5. Bissell M. J., Radisky D., Putting tumours in context Nature Reviews Cancer 2001 1 1 46 54 (Pubitemid 33741880)
6. Tlsty T. D., Stromal cells can contribute oncogenic signals Seminars in Cancer Biology 2001 11 2 97 104 (Pubitemid 32423285)
7. Tlsty T. D., Hein P. W., Know thy neighbor: stromal cells can contribute oncogenic signals Current Opinion in Genetics and Development 2001 11 1 54 59 (Pubitemid 32119278)
8. Karnoub A. E., Dash A. B., Vo A. P., Sullivan A., Brooks M. W., Bell G. W., Richardson A. L., Polyak K., Tubo R., Weinberg R. A., Mesenchymal stem cells within tumour stroma promote breast cancer metastasis Nature 2007 449 7162 557 563 (Pubitemid 47525152)
9. Bhowmick N. A., Chytil A., Plieth D., Gorska A. E., Dumont N., Shappell S., Washington M. K., Neilson E. G., Moses H. L., TGF- signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia Science 2004 303 5659 848 851 (Pubitemid 38174665)
10. Campbell S. M., Taha M. M., Medina D., Rosen J. M., A clonal derivative of mammary epithelial cell line COMMA-D retains stem cell characteristics of unique morphological and functional heterogeneity Experimental Cell Research 1988 177 1 109 121
11. Lin E. Y., Pollard J. W., Tumor-associated macrophages press the angiogenic switch in breast cancer Cancer Research 2007 67 11 5064 5066 (Pubitemid 46997238)
12. Lewis C. E., Hughes R., Inflammation and breast cancer. Microenvironmental factors regulating macrophage function in breast tumours: hypoxia and angiopoietin-2 Breast Cancer Research 2007 9 3, article 209
13. Ulrich C. M., Bigler J., Potter J. D., Non-steroidal anti-inflammatory drugs for cancer prevention: promise, perils and pharmacogenetics Nature Reviews Cancer 2006 6 2 130 140 (Pubitemid 43361545)
14. Singer C. F., Gschwantler-Kaulich D., Fink-Retter A., Haas C., Hudelist G., Czerwenka K., Kubista E., Differential gene expression profile in breast cancer-derived stromal fibroblasts Breast Cancer Research and Treatment 2008 110 2 273 281 (Pubitemid 351793881)
15. Sahab Z. J., Suh Y., Sang Q. X. A., Isoelectric point-based prefractionation of proteins from crude biological samples prior to two-dimensional gel electrophoresis Journal of Proteome Research 2005 4 6 2266 2272 (Pubitemid 41814296)
16. Sahab Z. J., Man Y. G., Semaan S. M., Newcomer R. G., Byers S. W., Sang Q. X. A., Alteration in protein expression in estrogen receptor alpha-negative human breast cancer tissues indicates a malignant and metastatic phenotype Clinical and Experimental Metastasis 2010 27 7 493 503
17. Khamis Z. I., Iczkowski K. A., Sahab Z. J., Sang Q. X., Protein profiling of isolated leukocytes, myofibroblasts, epithelial, basal, and endothelial cells from normal, hyperplastic, cancerous, and inflammatory human prostate tissues Journal of Cancer 2010 1 70 79
18. Sahab Z. J., Hall M. D., Zhang L., Cheema A. K., Byers S. W., Tumor suppressor RARRES1 regulates DLG2, PP2A, VCP, EB1, and Ankrd26 Journal of Cancer 2010 1 14 22
19. Sahab Z. J., Hall M. D., Sung Y. M., Dakshanamurthy S., Ji Y., Kumar D., Byers S. W., Tumor suppressor RARRES1 interacts with cytoplasmic carboxypeptidase AGBL2 to regulate the -tubulin tyrosination cycle Cancer Research 2011 71 4 1219 1228
20. Polyak K., Hu M., Do myoepithelial cells hold the key for breast tumor progression? Journal of mammary gland biology and neoplasia 2005 10 3 231 247
21. Man Y. G., Sang Q. X. A., The significance of focal myoepithelial cell layer disruptions in human breast tumor invasion: a paradigm shift from the "protease-centered" hypothesis Experimental Cell Research 2004 301 2 103 118
22. Man Y. G., Shen T., Weisz J., Berg P. E., Schwartz A. M., Mulshine J. L., Sang Q. X. A., Nieburgs H. E., A subset of in situ breast tumor cell clusters lacks expression of proliferation and progression related markers but shows signs of stromal and vascular invasion Cancer Detection and Prevention 2005 29 4 323 331 (Pubitemid 41267290)
23. Man Y. G., Tai L., Barner R., Vang R., Saenger J. S., Shekitka K. M., Bratthauer G. L., Wheeler D. T., Liang C. Y., Vinh T. N., Strauss B. L., Cell clusters overlying focally disrupted mammary myoepithelial cell layers and adjacent cells within the same duct display different immunohistochemical and genetic features: implications for tumor progression and invasion Breast Cancer Research 2003 5 6 R231 R241
24. McGuire W. L., Hormone receptors: their role in predicting prognosis and response to endocrine therapy Seminars in Oncology 1978 5 4 428 433 (Pubitemid 9097045)
25. Osborne C. K., Steroid hormone receptors in breast cancer management Breast Cancer Research and Treatment 1998 51 3 227 238 (Pubitemid 29054556)
26. Sheikh M. S., Garcia M., Pujol P., Fontana J. A., Rochefort H., Why are estrogen-receptor-negative breast cancers more aggressive than the estrogen-receptor-positive breast cancers? Invasion and Metastasis 1994 14 16 329 336
27. Ferguson A. T., Lapidus R. G., Baylin S. B., Davidson N. E., Demethylation of the estrogen receptor gene in estrogen receptor-negative breast cancer cells can reactivate estrogen receptor gene expression Cancer Research 1995 55 11 2279 2283
28. Stoner M., Saville B., Wormke M., Dean D., Burghardt R., Safe S., Hypoxia induces proteasome-dependent degradation of estrogen receptor in ZR-75 breast cancer cells Molecular Endocrinology 2002 16 10 2231 2242 (Pubitemid 35155536)
29. Shankaran V., Ikeda H., Bruce A. T., White J. M., Swanson P. E., Old L. J., Schreiber R. D., IFN, and lymphocytes prevent primary tumour development and shape tumour immunogenicity Nature 2001 410 6832 1107 1111 (Pubitemid 32391043)
30. David H., Rudolf Virchow and modern aspects of tumor pathology Pathology Research and Practice 1988 183 3 356 364
31. Lin E. Y., Nguyen A. V., Russell R. G., Pollard J. W., Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy Journal of Experimental Medicine 2001 193 6 727 739 (Pubitemid 32524466)
32. Pollard J. W., Tumour-educated macrophages promote tumour progression and metastasis Nature Reviews Cancer 2004 4 1 71 78 (Pubitemid 38082155)
33. Yokosuka T., Takase K., Suzuki M., Nakagawa Y., Taki S., Takahashi H., Fujisawa T., Arase H., Saito T., Predominant role of T cell receptor (TCR)- chain in forming preimmune TCR repertoire revealed by clonal TCR reconstitution system Journal of Experimental Medicine 2002 195 8 991 1001 (Pubitemid 34412001)
34. Zheng L., Pan H., Li S., Flesken-Nikitin A., Chen P. L., Boyer T. G., Lee W. H., Sequence-specific transcriptional corepressor function for BRCA1 through a novel zinc finger protein, ZBRK1 Molecular Cell 2000 6 4 757 768
35. Garcia V., Domnguez G., Garca J. M., Silva J., Pea C., Silva J. M., Carcereny E., Menendez J., Espaa P., Bonilla F., Altered expression of the ZBRK1 gene in human breast carcinomas Journal of Pathology 2004 202 2 224 232 (Pubitemid 38208660)
36. Marks J. R., Huper G., Vaughn J. P., Davis P. L., Norris J., McDonnell D. P., Wiseman R. W., Futreal P. A., Iglehart J. D., BRCA1 expression is not directly responsive to estrogen Oncogene 1997 14 1 115 121 (Pubitemid 27042961)
37. Furuta S., Wang J. M., Wei S., Jeng Y. M., Jiang X., Gu B., Chen P. L., Lee E. Y. H. P., Lee W. H., Removal of BRCA1/CtIP/ZBRK1 repressor complex on ANG1 promoter leads to accelerated mammary tumor growth contributed by prominent vasculature Cancer Cell 2006 10 1 13 24
38. Moinfar F., Man Y. G., Arnould L., Bratthauer G. L., Ratschek M., Tavassoli F. A., Concurrent and independent genetic alterations in the stromal and epithelial cells of mammary carcinoma: implications for tumorigenesis Cancer Research 2000 60 9 2562 2566 (Pubitemid 30262453)